Clémentine Ravache

Clémentine Ravache has a diverse work experience in finance and accounting. Clémentine is currently working as the Deputy Chief Financial Officer at GenSight Biologics since November 2022. Prior to that, they held the role of Senior Vice President Finance at DBV Technologies from May 2016 to April 2022. At DBV Technologies, they played a key role in the development of their technology platform for immunotherapy. Before joining DBV Technologies, Clémentine worked at Deloitte for almost 9 years, starting in the Audit department from 2007 to 2014 and then as part of the Accounting Advisory and Capital Markets practice from 2014 to 2016. At Deloitte, they gained extensive experience in working with growth companies in areas such as IPOs, risk management, and financial reporting.

Clémentine Ravache's education history begins in 2002 when they attended the European School of Business - Reutlingen. Here, they pursued a Bachelor of Business Administration (BBA) degree with a focus on corporate finance. Clémentine completed their studies in 2004.

In 2004, Clémentine went on to attend NEOMA Business School, where they pursued a Bachelor of Business Administration (BBA) degree once again, with a specialization in corporate finance. Clémentine completed their studies in 2006.

Following this, in 2006, Clémentine enrolled at the Paris School of Business, where they pursued a Master of Business Administration (MBA) degree with a concentration in auditing and controlling. Clémentine completed their studies in 2007.

In summary, Clémentine Ravache obtained a Bachelor of Business Administration degree in corporate finance from both European School of Business - Reutlingen and NEOMA Business School. Clémentine later pursued a Master of Business Administration degree with a specialization in auditing and controlling from the Paris School of Business.